Antonio Spadea Selected Research

Lenograstim

1/2024	Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.
1/2018	Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
2/2016	Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.
11/2010	Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Spadea Research Topics

Disease

8	Lymphoma (Lymphomas) 01/2024 - 11/2010
6	Neoplasms (Cancer) 01/2021 - 01/2012
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2002
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2016 - 03/2005
3	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 03/2015
3	Leukemia 01/2017 - 05/2015
3	Infections 09/2015 - 02/2012
2	Essential Thrombocythemia 01/2021 - 09/2020
2	Polycythemia Vera 01/2021 - 01/2013
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 11/2010
2	Multiple Myeloma 09/2019 - 03/2016
2	Mycoses (Diseases, Fungus) 03/2019 - 02/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 02/2013
2	Residual Neoplasm 01/2017 - 03/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2015 - 02/2012
1	Febrile Neutropenia 01/2020
1	Polyneuropathies (Polyneuropathy) 09/2019
1	Bacterial Infections (Bacterial Infection) 03/2019
1	Latent Infection 03/2019
1	Neutropenia 03/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2018
1	Heart Diseases (Heart Disease) 02/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Splenomegaly 03/2016
1	Thrombosis (Thrombus) 03/2016
1	Autoimmune Diseases (Autoimmune Disease) 05/2015
1	Invasive Fungal Infections 02/2015
1	Exanthema (Rash) 10/2014
1	Muscle Cramp (Cramp) 10/2014
1	Anemia 10/2014
1	Aspergillosis 06/2013
1	Bacteremia 06/2013
1	Cytomegalovirus Infections (Inclusion Disease) 02/2012
1	Philadelphia Chromosome 01/2012
1	Leukocytosis (Pleocytosis) 12/2002

Drug/Important Bio-Agent (IBA)

4	LenograstimIBA 01/2024 - 11/2010
4	Imatinib Mesylate (Gleevec)FDA Link 11/2016 - 03/2005
3	Filgrastim (Neupogen)FDA Link 01/2024 - 02/2016
3	Biosimilar PharmaceuticalsIBA 01/2024 - 02/2016
2	Immunoglobulin G (IgG)IBA 01/2021 - 09/2015
2	ruxolitinibIBA 01/2021 - 03/2017
2	Rituximab (Mabthera)FDA Link 02/2018 - 02/2012
2	Antiviral Agents (Antivirals)IBA 09/2015 - 02/2012
2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2013 - 01/2012
1	venetoclaxIBA 01/2023
1	VaccinesIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	anagrelide (Agrylin)FDA LinkGeneric 09/2020
1	tazobactam drug combination ceftolozaneIBA 01/2020
1	Pregabalin (Lyrica)FDA Link 09/2019
1	Prostaglandins BIBA 09/2019
1	Bortezomib (Velcade)FDA Link 03/2019
1	Biomarkers (Surrogate Marker)IBA 03/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018
1	liposomal doxorubicin (Doxil)FDA Link 02/2018
1	Prednisone (Sone)FDA LinkGeneric 02/2018
1	Vincristine (Oncovin)FDA LinkGeneric 02/2018
1	SteroidsIBA 01/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	ponatinibIBA 01/2017
1	SuspensionsIBA 07/2016
1	posaconazole FDA Link 07/2016
1	Deferasirox FDA Link 06/2016
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 03/2016
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	Hemoglobins (Hemoglobin)IBA 03/2015
1	galactomannanIBA 06/2013

Therapy/Procedure

8	Therapeutics 01/2023 - 02/2012
6	Drug Therapy (Chemotherapy) 01/2018 - 12/2002
3	Stem Cell Transplantation 03/2019 - 02/2012
2	Drug Tapering 09/2019 - 10/2014
1	Polypharmacy 11/2016
1	Hematopoietic Stem Cell Transplantation 02/2012
1	Immunotherapy 02/2012
1	Conservative Treatment 12/2002